Large granular lymphocytic leukaemia after solid organ and haematopoietic stem cell transplantation.


Journal

British journal of haematology
ISSN: 1365-2141
Titre abrégé: Br J Haematol
Pays: England
ID NLM: 0372544

Informations de publication

Date de publication:
04 2020
Historique:
received: 07 07 2019
revised: 04 09 2019
accepted: 09 09 2019
pubmed: 21 1 2020
medline: 15 12 2020
entrez: 21 1 2020
Statut: ppublish

Résumé

T-cell large granular lymphocytic leukaemia (T-LGLL) is a chronic clonal lymphoproliferative disorder of cytotoxic T lymphocytes which commonly occurs in older patients and is often associated with autoimmune diseases. Among 246 patients with T-LGLL seen at our institution over the last 10 years, we encountered 15 cases following solid organ or haematopoietic stem cell transplantation. Here, we studied the clinical characterization of these cases and compared them to de novo T-LGLL. This experience represented a clear picture of the intricate nature of the disease manifestation and the complexities of several immune mechanisms triggering the clonal expansion.

Identifiants

pubmed: 31958160
doi: 10.1111/bjh.16336
pmc: PMC8370478
mid: NIHMS1054457
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

318-322

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL118281
Pays : United States
Organisme : NIH HHS
Pays : United States
Organisme : NHLBI NIH HHS
ID : R35 HL135795
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL123904
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL132071
Pays : United States

Informations de copyright

© 2019 British Society for Haematology and John Wiley & Sons Ltd.

Références

Oncotarget. 2017 Sep 18;8(46):81697-81708
pubmed: 29113425
Leuk Lymphoma. 2008 May;49(5):932-8
pubmed: 18452068
N Engl J Med. 2012 May 17;366(20):1905-13
pubmed: 22591296
Leukemia. 2002 Oct;16(10):2129-33
pubmed: 12357367
Stem Cell Investig. 2015 Sep 28;2:17
pubmed: 27358885
Biol Blood Marrow Transplant. 2012 Nov;18(11):1765-70
pubmed: 22796340
Exp Hematol. 2004 Oct;32(10):1010-22
pubmed: 15504556
Blood. 2016 May 19;127(20):2375-90
pubmed: 26980727
Leuk Lymphoma. 2018 Feb;59(2):416-422
pubmed: 28633612
Blood Cancer J. 2013 Dec 06;3:e168
pubmed: 24317090
J Immunol. 2007 Aug 1;179(3):2013-22
pubmed: 17641069
Blood. 1994 Jan 15;83(2):587-95
pubmed: 7506956
Transplant Proc. 2006 Dec;38(10):3437-40
pubmed: 17175296

Auteurs

Hassan Awada (H)

Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

Reda Z Mahfouz (RZ)

Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

Jibran Durrani (J)

Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

Ashwin Kishtagari (A)

Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

Deepa Jagadeesh (D)

Lymphoid Malignancies Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

Alan E Lichtin (AE)

Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

Brian T Hill (BT)

Lymphoid Malignancies Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

Betty K Hamilton (BK)

Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

Hetty E Carraway (HE)

Leukaemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

Aziz Nazha (A)

Leukaemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

Navneet S Majhail (NS)

Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

Ronald Sobecks (R)

Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

Valeria Visconte (V)

Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

Matt Kalaycio (M)

Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

Mikkael A Sekeres (MA)

Leukaemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

Jaroslaw P Maciejewski (JP)

Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH